2. Academic Validation
  3. Depot-specific UCP1 expression in human white adipose tissue and its association with obesity-related markers

Depot-specific UCP1 expression in human white adipose tissue and its association with obesity-related markers

  • Int J Obes (Lond). 2020 Mar;44(3):697-706. doi: 10.1038/s41366-020-0528-4.
Jisun Lim 1,  Hye Soon Park  # 2,  Jimin Kim 3,  Yeon Jin Jang  # 4,  Jong-Hyeok Kim 5,  YeonJi Lee 6,  Yoonseok Heo 7
Affiliations

Affiliations

  • 1 Department of Family Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • 2 Department of Family Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. hyesoon@amc.seoul.kr.
  • 3 Department of Physiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • 4 Department of Physiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. yjjang@amc.seoul.kr.
  • 5 Department of Obstetrics and Gynecology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • 6 Department of Family Medicine, College of Medicine, Inha University, Incheon, Republic of Korea.
  • 7 Department of General Surgery, College of Medicine, Inha University, Incheon, Republic of Korea.
  • # Contributed equally.
PMID: 31965068 DOI: 10.1038/s41366-020-0528-4
Abstract

Background: This study investigated depot-specific mRNA expression of uncoupling protein 1 (UCP1) in human white adipose tissue (WAT) and its association with obesity-related markers.

Methods: We recruited 39 normal-weight, 41 nondiabetic obese, and 22 diabetic obese women. We measured UCP1 mRNA expression in abdominal visceral adipose tissue (VAT) and subcutaneous adipose tissue (SAT), and investigated the associations between UCP1 mRNA expression in VAT and SAT, and obesity-related markers including mRNA expression of Leptin, Adiponectin, CCAAT-enhancer-binding protein homologous protein (CHOP), and positive regulatory domain-containing protein 16 (PRDM16). We also evaluated UCP1 mRNA expression in differentiated human white adipocytes after treatment with various stressors and metabolic improvement agents in vitro.

Results: UCP1 mRNA in VAT was significantly higher than in SAT in all groups. UCP1 mRNA in SAT was negatively correlated with BMI, total abdominal fat area, visceral fat area, blood pressure, fasting glucose, Insulin, HOMA-IR score, triglyceride, hsCRP, fasting Leptin levels, and adipocyte size. UCP1 mRNA in SAT was positively correlated with fasting Adiponectin levels. UCP1 mRNA in VAT was negatively correlated with visceral-to-subcutaneous fat ratio (VSR), fasting glucose, and triglyceride levels. In SAT, UCP1 mRNA was negatively correlated with mRNA expression of Leptin and CHOP, and positively correlated with mRNA expression of Adiponectin. The expression of PRDM16 was positively correlated with UCP1 mRNA in both VAT and SAT. UCP1 mRNA expression in differentiated human white adipocytes was significantly reduced after incubation with thapsigargin, tunicamycin, homocysteine, TNF-α, or IL-β, and significantly increased after incubation with exendin 4, dapagliflozin, and telmisartan.

Conclusions: This study demonstrated depot-specific mRNA expression of UCP1 and its association with obesity-related markers in human WAT. UCP1 mRNA in human white adipocytes was suppressed by inflammatory agents and enhanced by metabolic improvement agents. UCP1 in human WAT might participate in the pathogenesis of obesity-related metabolic diseases.

Figures
Products